MD3098G2 - Dihydrate of di( -Ophenoxy)-di[N-(2-oxy-1-benzal)-N1- -oxyfuralhydrazine(2-)copper] with properties of inhibitor of the human myeloid leukemia - Google Patents
Dihydrate of di( -Ophenoxy)-di[N-(2-oxy-1-benzal)-N1- -oxyfuralhydrazine(2-)copper] with properties of inhibitor of the human myeloid leukemiaInfo
- Publication number
- MD3098G2 MD3098G2 MDA20060022A MD20060022A MD3098G2 MD 3098 G2 MD3098 G2 MD 3098G2 MD A20060022 A MDA20060022 A MD A20060022A MD 20060022 A MD20060022 A MD 20060022A MD 3098 G2 MD3098 G2 MD 3098G2
- Authority
- MD
- Moldova
- Prior art keywords
- myeloid leukemia
- human myeloid
- oxyfuralhydrazine
- ophenoxy
- benzal
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to chemistry, namely to the synthesis of the coordinative compounds from the class of aroylhydrazonates of the transition metals and may find its application in medicine for prophylaxis and treatment of the human myeloid leukemia.Summary of the invention consists in that as inhibitor of the human myeloid leukemia is proposed dihydrate of di((µ-Ophenoxy)-di[N-(2-oxy-1-benzal)-N1-α-oxyfuralhydrazine(2-)copper] of formula:The result of the invention consists in the synthesis of the compound, extending the spectrum of highly active inhibitors of the human myeloid leukemia.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20060022A MD3098G2 (en) | 2006-01-03 | 2006-01-03 | Dihydrate of di( -Ophenoxy)-di[N-(2-oxy-1-benzal)-N1- -oxyfuralhydrazine(2-)copper] with properties of inhibitor of the human myeloid leukemia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20060022A MD3098G2 (en) | 2006-01-03 | 2006-01-03 | Dihydrate of di( -Ophenoxy)-di[N-(2-oxy-1-benzal)-N1- -oxyfuralhydrazine(2-)copper] with properties of inhibitor of the human myeloid leukemia |
Publications (2)
Publication Number | Publication Date |
---|---|
MD3098F1 MD3098F1 (en) | 2006-07-31 |
MD3098G2 true MD3098G2 (en) | 2007-02-28 |
Family
ID=36808910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20060022A MD3098G2 (en) | 2006-01-03 | 2006-01-03 | Dihydrate of di( -Ophenoxy)-di[N-(2-oxy-1-benzal)-N1- -oxyfuralhydrazine(2-)copper] with properties of inhibitor of the human myeloid leukemia |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD3098G2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD3655G2 (en) * | 2007-09-03 | 2009-02-28 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia on base of bis(2-hydroxy-8-phenyl-tricyclo/7.3.1.0.2,7/-tridecane-13-on-thiosemicarbazonato)copper |
MD20110040A1 (en) * | 2011-05-10 | 2012-11-30 | Государственный Университет Молд0 | Inhibitors of human myeloid leukemia based on 2-[2-(pyridine-2-ilmethylidene)hydrazine]-1,3-benzothiazole and 2-[2-(1-pyridine-2-ilethylidene)hydrazine]-1,3-benzothiazole dihydrate |
MD4190C1 (en) * | 2011-06-16 | 2013-07-31 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia based on {bis[2-(3,5-dibrom-2-hydroxyphenyl)-2-oxoethyl-piperidin-1-carbodithioato(1-)-O,O′]copper} |
MD4215C1 (en) * | 2012-07-09 | 2013-11-30 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide |
MD4327C1 (en) * | 2013-10-22 | 2015-09-30 | Институт Химии Академии Наук Молдовы | N-(D8,13-Bicyclohomofarnesenoyl)-3-amino-1,2,4-triazole compound and process for cultivation of Nostoc linckia cyanobacterium with its use |
MD4326C1 (en) * | 2013-10-22 | 2015-09-30 | Институт Химии Академии Наук Молдовы | N-(D8,13-Bicyclohomofarnesenoylamino)carbazole compound and process for cultivation of Nostoc linckia cyanobacterium with its use |
MD4393C1 (en) * | 2015-09-04 | 2016-08-31 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia HL-60 cells based on nitrato-[N′-(1-pyridine-2-ylmethylidene)-morpholine-4-carbothiohydrazido(1-)]copper |
MD4407C1 (en) * | 2015-04-29 | 2016-10-31 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD2851F1 (en) * | 2004-08-12 | 2005-09-30 | Universitatea De Stat Din Moldova | Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer |
-
2006
- 2006-01-03 MD MDA20060022A patent/MD3098G2/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD2851F1 (en) * | 2004-08-12 | 2005-09-30 | Universitatea De Stat Din Moldova | Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD3655G2 (en) * | 2007-09-03 | 2009-02-28 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia on base of bis(2-hydroxy-8-phenyl-tricyclo/7.3.1.0.2,7/-tridecane-13-on-thiosemicarbazonato)copper |
MD20110040A1 (en) * | 2011-05-10 | 2012-11-30 | Государственный Университет Молд0 | Inhibitors of human myeloid leukemia based on 2-[2-(pyridine-2-ilmethylidene)hydrazine]-1,3-benzothiazole and 2-[2-(1-pyridine-2-ilethylidene)hydrazine]-1,3-benzothiazole dihydrate |
MD4190C1 (en) * | 2011-06-16 | 2013-07-31 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia based on {bis[2-(3,5-dibrom-2-hydroxyphenyl)-2-oxoethyl-piperidin-1-carbodithioato(1-)-O,O′]copper} |
MD4215C1 (en) * | 2012-07-09 | 2013-11-30 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide |
MD4327C1 (en) * | 2013-10-22 | 2015-09-30 | Институт Химии Академии Наук Молдовы | N-(D8,13-Bicyclohomofarnesenoyl)-3-amino-1,2,4-triazole compound and process for cultivation of Nostoc linckia cyanobacterium with its use |
MD4326C1 (en) * | 2013-10-22 | 2015-09-30 | Институт Химии Академии Наук Молдовы | N-(D8,13-Bicyclohomofarnesenoylamino)carbazole compound and process for cultivation of Nostoc linckia cyanobacterium with its use |
MD4407C1 (en) * | 2015-04-29 | 2016-10-31 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate |
MD4393C1 (en) * | 2015-09-04 | 2016-08-31 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia HL-60 cells based on nitrato-[N′-(1-pyridine-2-ylmethylidene)-morpholine-4-carbothiohydrazido(1-)]copper |
Also Published As
Publication number | Publication date |
---|---|
MD3098F1 (en) | 2006-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD3098G2 (en) | Dihydrate of di( -Ophenoxy)-di[N-(2-oxy-1-benzal)-N1- -oxyfuralhydrazine(2-)copper] with properties of inhibitor of the human myeloid leukemia | |
MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
TW200716606A (en) | Chemical compounds | |
TW200800963A (en) | Chemical compounds | |
HK1113352A1 (en) | Chemical compounds | |
HK1114375A1 (en) | Chemical compounds | |
EA200802050A1 (en) | NEW HETEROARYLIC-SUBSTITUTED ARYLAMINOPIRIDINE DERIVATIVES AS MEK INHIBITORS | |
IL178675A0 (en) | Monocyclic heterocycles as kinase inhibitors | |
MX2009000884A (en) | Pyridizinone derivatives. | |
EA200700601A1 (en) | DERIVATIVES OF PHENYLAMINOPYRIMIDINE AS BCR-ABL INHIBITORS | |
ATE383360T1 (en) | 5-AMINO-2,4,7-TRIOXO-3,4,7,8-TETRAHYDRO-2H-PYRIDO(2,3-D)PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CANCER | |
GEP20146102B (en) | Compounds and compositions as protein kinase inhibitors | |
MY171866A (en) | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | |
GEP20166443B (en) | Heterocyclic compound and use thereof | |
MD3655F1 (en) | Inhibitor of human myeloid leukemia on base of bis(2-hydroxy-8-phenyl-tricyclo/7.3.1.0.2,7/-tridecane-13-on-thiosemicarbazonato) | |
MX2009006473A (en) | Benzimidazole trpv1 inhibitors. | |
WO2006047415A3 (en) | FACTOR Xa COMPOUNDS | |
EP2004177A4 (en) | Nitrofuran compounds for the treatment of cancer and angiogenesis | |
TNSN08020A1 (en) | 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them | |
WO2006108680A3 (en) | Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against protozoa and helminthes | |
SG158091A1 (en) | Imidazoazepinone compounds | |
WO2008073332A3 (en) | Creatine compositions for skin treatment | |
MY153733A (en) | Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same | |
TW200602023A (en) | Monocyclic heterocycles as kinase inhibitors | |
MD4393C1 (en) | Inhibitor of human myeloid leukemia HL-60 cells based on nitrato-[N′-(1-pyridine-2-ylmethylidene)-morpholine-4-carbothiohydrazido(1-)]copper |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |